ArticleNpj viruses2026
Investigation and impact of mammalian adaptation markers on H5N8 high pathogenicity avian influenza polymerase activity.
Article in Npj viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Highly pathogenic H5Nx viruses of clade 2.3.4.4b have spread worldwide, causing major economic losses and increased human exposure. Since 2020, multiple mammalian infections have been reported, raising concerns about further adaptation to mammalian hosts. We analyzed influenza A virus sequences from the Influenza Virus Database at the National Center for Biotechnology Information to identify new mammalian adaptation markers in the polymerase complex and nucleoprotein, using recursive partitioning. These markers were grouped into "proteotypes" to assess their co-occurrence and association with host origin. This analysis revealed distinct groups of proteotypes linked to mammalian adaptation, including those seen in historical and pandemic human strains. Identified mutations were introduced alone or in combination into a 2.3.4.4b H5N8 virus to evaluate their impact on polymerase activity in mammalian cells using a minigenome assay. PB1 V336I and PB2 K702R increased polymerase activity in human cells, particularly with PB2 E627K, supporting enhanced surveillance of 2.3.4.4b H5Nx viruses. These findings highlight mutation combinations relevant for enhanced surveillance of 2.3.4.4b H5Nx viruses.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.